Real World Data in Health Technology Assessment of Complex Health Technologies

The available evidence on relative effectiveness and risks of new health technologies is often limited at the time of health technology assessment (HTA). Additionally, a wide variety in real-world data (RWD) policies exist among HTA organizations. This study assessed which challenges, related to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogervorst, Milou A., Pontén, Johan, Vreman, Rick A., Mantel-Teeuwisse, Aukje K., Goettsch, Wim G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866967/
https://www.ncbi.nlm.nih.gov/pubmed/35222045
http://dx.doi.org/10.3389/fphar.2022.837302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866967/
https://www.ncbi.nlm.nih.gov/pubmed/35222045
http://dx.doi.org/10.3389/fphar.2022.837302

Ejemplares similares